Kinnate Biopharma Inc. Gains 59.24%
Wed, Nov 15, 2023 at 07:48 PM
Kinnate Biopharma Inc. (KNTE:NASDAQ) jumped higher at $2.5, representing a gain of 59.2%. On Wed, Nov 15, 2023, KNTE:NASDAQ hit a New 2-Week High of $2.5. The stock appeared on our News Catalysts scanner on Thu, Nov 09, 2023 at 06:13 PM in the 'INVESTOR UPDATE' category. From Thu, Nov 02, 2023, the stock recorded 44.44% Up Days and 60.00% Green Days
About Kinnate Biopharma Inc. (KNTE:NASDAQ)
Kinnate Biopharma Inc a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers.
Top 10 Gainers:
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 83.64%
- MIRA Pharmaceuticals Inc. (MIRA:NASDAQ), 72.51%
- Heron Therapeutics, Inc. (HRTX:NASDAQ), 59.26%
- Kinnate Biopharma Inc. (KNTE:NASDAQ), 59.24%
- Ebix, Inc. (EBIX:NASDAQ), 57.66%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 50%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 49.7%
- SciSparc Ltd. (SPRC:NASDAQ), 48.17%
- The Beauty Health Company (SKIN:NASDAQ), 36.69%
- ZK International Group Co., Ltd. (ZKIN:NASDAQ), 36.27%